Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Exploratory Study of Predicted Indirectly ReCognizable HLA Epitopes in Mismatched Hematopoietic Cell Transplantations.

Geneugelijk K, Thus KA, van Deutekom HWM, Calis JJA, Borst E, Keşmir C, Oudshoorn M, van der Holt B, Meijer E, Zeerleder S, de Groot MR, von dem Borne PA, Schaap N, Cornelissen J, Kuball J, Spierings E.

Front Immunol. 2019 Apr 24;10:880. doi: 10.3389/fimmu.2019.00880. eCollection 2019.

2.

Accuracy of NGS HLA typing data influenced by STR.

van Deutekom HWM, Mulder W, Rozemuller EH.

Hum Immunol. 2019 Jul;80(7):461-464. doi: 10.1016/j.humimm.2019.03.007. Epub 2019 Mar 26.

PMID:
30926353
3.

Natural genetic variation of the cardiac transcriptome in non-diseased donors and patients with dilated cardiomyopathy.

Heinig M, Adriaens ME, Schafer S, van Deutekom HWM, Lodder EM, Ware JS, Schneider V, Felkin LE, Creemers EE, Meder B, Katus HA, Rühle F, Stoll M, Cambien F, Villard E, Charron P, Varro A, Bishopric NH, George AL Jr, Dos Remedios C, Moreno-Moral A, Pesce F, Bauerfeind A, Rüschendorf F, Rintisch C, Petretto E, Barton PJ, Cook SA, Pinto YM, Bezzina CR, Hubner N.

Genome Biol. 2017 Sep 14;18(1):170. doi: 10.1186/s13059-017-1286-z.

4.

A Previous Miscarriage and a Previous Successful Pregnancy Have a Different Impact on HLA Antibody Formation during a Subsequent Successful Pregnancy.

Geneugelijk K, Hönger G, van Deutekom HW, Hösli IM, Schaub S, Spierings E.

Front Immunol. 2016 Dec 6;7:571. doi: 10.3389/fimmu.2016.00571. eCollection 2016.

5.

A mutation in the glutamate-rich region of RNA-binding motif protein 20 causes dilated cardiomyopathy through missplicing of titin and impaired Frank-Starling mechanism.

Beqqali A, Bollen IA, Rasmussen TB, van den Hoogenhof MM, van Deutekom HW, Schafer S, Haas J, Meder B, Sørensen KE, van Oort RJ, Mogensen J, Hubner N, Creemers EE, van der Velden J, Pinto YM.

Cardiovasc Res. 2016 Oct;112(1):452-63. doi: 10.1093/cvr/cvw192. Epub 2016 Aug 5.

PMID:
27496873
6.

Screening for pulmonary tuberculosis in a Tanzanian prison and computer-aided interpretation of chest X-rays.

Steiner A, Mangu C, van den Hombergh J, van Deutekom H, van Ginneken B, Clowes P, Mhimbira F, Mfinanga S, Rachow A, Reither K, Hoelscher M.

Public Health Action. 2015 Dec 21;5(4):249-54. doi: 10.5588/pha.15.0037.

7.

Genome-Wide Polyadenylation Maps Reveal Dynamic mRNA 3'-End Formation in the Failing Human Heart.

Creemers EE, Bawazeer A, Ugalde AP, van Deutekom HW, van der Made I, de Groot NE, Adriaens ME, Cook SA, Bezzina CR, Hubner N, van der Velden J, Elkon R, Agami R, Pinto YM.

Circ Res. 2016 Feb 5;118(3):433-8. doi: 10.1161/CIRCRESAHA.115.307082. Epub 2015 Dec 15. Erratum in: Circ Res. 2016 Oct 14;119(9):e139.

PMID:
26671978
8.

Predicted Indirectly Recognizable HLA Epitopes Presented by HLA-DRB1 Are Related to HLA Antibody Formation During Pregnancy.

Geneugelijk K, Hönger G, van Deutekom HW, Thus KA, Keşmir C, Hösli I, Schaub S, Spierings E.

Am J Transplant. 2015 Dec;15(12):3112-22. doi: 10.1111/ajt.13508. Epub 2015 Oct 29.

9.

Zooming into the binding groove of HLA molecules: which positions and which substitutions change peptide binding most?

van Deutekom HW, Keşmir C.

Immunogenetics. 2015 Aug;67(8):425-36. doi: 10.1007/s00251-015-0849-y. Epub 2015 Jun 4.

10.

Atrial fibrillation is an independent risk factor for ventricular fibrillation: a large-scale population-based case-control study.

Bardai A, Blom MT, van Hoeijen DA, van Deutekom HW, Brouwer HJ, Tan HL.

Circ Arrhythm Electrophysiol. 2014 Dec;7(6):1033-9. doi: 10.1161/CIRCEP.114.002094. Epub 2014 Sep 18.

PMID:
25236735
11.

Refinement of the definition of permissible HLA-DPB1 mismatches with predicted indirectly recognizable HLA-DPB1 epitopes.

Thus KA, Ruizendaal MT, de Hoop TA, Borst E, van Deutekom HW, Te Boome L, Kuball J, Spierings E.

Biol Blood Marrow Transplant. 2014 Nov;20(11):1705-10. doi: 10.1016/j.bbmt.2014.06.026. Epub 2014 Jun 26.

12.

Summary of the Dutch S3-guidelines on the treatment of psoriasis 2011. Dutch Society of Dermatology and Venereology.

Zweegers J, de Jong EM, Nijsten TE, de Bes J, te Booij M, Borgonjen RJ, van Cranenburgh OD, van Deutekom H, van Everdingen JJ, de Groot M, Van Hees CL, Hulshuizen H, Koek MB, de Korte WJ, de Korte J, Lecluse LL, Pasch MC, Poblete-Gutiérrez PA, Prens EP, Seyger MM, Thio HB, Torcque LA, de Vries AC, van de Kerkhof PC, Spuls PI.

Dermatol Online J. 2014 Mar 17;20(3). pii: doj_21769.

13.

Tuberculosis control in big cities and urban risk groups in the European Union: a consensus statement.

van Hest NA, Aldridge RW, de Vries G, Sandgren A, Hauer B, Hayward A, Arrazola de Oñate W, Haas W, Codecasa LR, Caylà JA, Story A, Antoine D, Gori A, Quabeck L, Jonsson J, Wanlin M, Orcau Å, Rodes A, Dedicoat M, Antoun F, van Deutekom H, Keizer S, Abubakar I.

Euro Surveill. 2014 Mar 6;19(9). pii: 20728.

14.

HIV-1 evolution in patients undergoing immunotherapy with Tat, Rev, and Nef expressing dendritic cells followed by treatment interruption.

de Goede AL, van Deutekom HW, Vrancken B, Schutten M, Allard SD, van Baalen CA, Osterhaus AD, Thielemans K, Aerts JL, Keşmir C, Lemey P, Gruters RA.

AIDS. 2013 Nov 13;27(17):2679-89. doi: 10.1097/01.aids.0000433813.67662.92.

PMID:
24149085
15.

The rate of immune escape vanishes when multiple immune responses control an HIV infection.

van Deutekom HW, Wijnker G, de Boer RJ.

J Immunol. 2013 Sep 15;191(6):3277-86. doi: 10.4049/jimmunol.1300962. Epub 2013 Aug 12.

16.

Inferring patient to patient transmission of Mycobacterium tuberculosis from whole genome sequencing data.

Bryant JM, Schürch AC, van Deutekom H, Harris SR, de Beer JL, de Jager V, Kremer K, van Hijum SA, Siezen RJ, Borgdorff M, Bentley SD, Parkhill J, van Soolingen D.

BMC Infect Dis. 2013 Feb 27;13:110. doi: 10.1186/1471-2334-13-110.

17.

Role of the QuantiFERON(R)-TB Gold In-Tube assay in screening new immigrants for tuberculosis infection.

Mulder C, van Deutekom H, Huisman EM, Toumanian S, Koster BF, Meijer-Veldman W, van Loenhout-Rooyackers JH, Appel M, Arend SM, Borgdorff MW, van Leth F.

Eur Respir J. 2012 Dec;40(6):1443-9. doi: 10.1183/09031936.00010612. Epub 2012 Apr 10.

18.

High sensitivity of chest radiograph reading by clinical officers in a tuberculosis prevalence survey.

Hoog AH, Meme HK, van Deutekom H, Mithika AM, Olunga C, Onyino F, Borgdorff MW.

Int J Tuberc Lung Dis. 2011 Oct;15(10):1308-14. doi: 10.5588/ijtld.11.0004.

PMID:
22283886
19.

Coverage and yield of tuberculosis contact investigations in the Netherlands.

Mulder C, van Deutekom H, Huisman EM, Meijer-Veldman W, Erkens CG, van Rest J, Borgdorff MW, van Leth F.

Int J Tuberc Lung Dis. 2011 Dec;15(12):1630-7. doi: 10.5588/ijtld.11.0027.

PMID:
22118170
20.

A comparative analysis of viral peptides presented by contemporary human and chimpanzee MHC class I molecules.

van Deutekom HW, Hoof I, Bontrop RE, Keşmir C.

J Immunol. 2011 Dec 1;187(11):5995-6001. doi: 10.4049/jimmunol.1102236. Epub 2011 Oct 31.

21.

Loss of HIV-1-derived cytotoxic T lymphocyte epitopes restricted by protective HLA-B alleles during the HIV-1 epidemic.

Schellens IM, Navis M, van Deutekom HW, Boeser-Nunnink B, Berkhout B, Kootstra N, Miedema F, Keşmir C, Schuitemaker H, van Baarle D, Borghans JA.

AIDS. 2011 Sep 10;25(14):1691-700. doi: 10.1097/QAD.0b013e32834981b3.

PMID:
21681058
22.

Mycobacterial factors relevant for transmission of tuberculosis.

Verhagen LM, van den Hof S, van Deutekom H, Hermans PW, Kremer K, Borgdorff MW, van Soolingen D.

J Infect Dis. 2011 May 1;203(9):1249-55. doi: 10.1093/infdis/jir013. Epub 2011 Mar 4.

PMID:
21378376
23.

A consensus of core protein complex compositions for Saccharomyces cerevisiae.

Benschop JJ, Brabers N, van Leenen D, Bakker LV, van Deutekom HW, van Berkum NL, Apweiler E, Lijnzaad P, Holstege FC, Kemmeren P.

Mol Cell. 2010 Jun 25;38(6):916-28. doi: 10.1016/j.molcel.2010.06.002.

24.

Dominant processes during human dendritic cell maturation revealed by integration of proteome and transcriptome at the pathway level.

Buschow SI, Lasonder E, van Deutekom HW, Oud MM, Beltrame L, Huynen MA, de Vries IJ, Figdor CG, Cavalieri D.

J Proteome Res. 2010 Apr 5;9(4):1727-37. doi: 10.1021/pr9008546.

PMID:
20131907
25.

Tuberculosis outbreaks predicted by characteristics of first patients in a DNA fingerprint cluster.

Kik SV, Verver S, van Soolingen D, de Haas PE, Cobelens FG, Kremer K, van Deutekom H, Borgdorff MW.

Am J Respir Crit Care Med. 2008 Jul 1;178(1):96-104. doi: 10.1164/rccm.200708-1256OC. Epub 2008 Apr 3.

PMID:
18388352
26.

[HIV-test policy for tuberculosis patients in the Netherlands].

Haar CH, Cobelens FG, Kalisvaart NA, van der Have JJ, van Deutekom H.

Ned Tijdschr Geneeskd. 2007 Dec 1;151(48):2674-9. Dutch.

PMID:
18179086
27.

Protein kinase B (c-akt) regulates hematopoietic lineage choice decisions during myelopoiesis.

Buitenhuis M, Verhagen LP, van Deutekom HW, Castor A, Verploegen S, Koenderman L, Jacobsen SE, Coffer PJ.

Blood. 2008 Jan 1;111(1):112-21. Epub 2007 Sep 21.

PMID:
17890457
28.

Proposal for standardization of optimized mycobacterial interspersed repetitive unit-variable-number tandem repeat typing of Mycobacterium tuberculosis.

Supply P, Allix C, Lesjean S, Cardoso-Oelemann M, Rüsch-Gerdes S, Willery E, Savine E, de Haas P, van Deutekom H, Roring S, Bifani P, Kurepina N, Kreiswirth B, Sola C, Rastogi N, Vatin V, Gutierrez MC, Fauville M, Niemann S, Skuce R, Kremer K, Locht C, van Soolingen D.

J Clin Microbiol. 2006 Dec;44(12):4498-510. Epub 2006 Sep 27.

29.

HIV prevalence among tuberculosis patients in The Netherlands, 1993-2001: trends and risk factors.

Haar CH, Cobelens FG, Kalisvaart NA, Van der Have JJ, Van Gerven PJ, Van Deutekom H.

Int J Tuberc Lung Dis. 2006 Jul;10(7):768-74.

PMID:
16848339
30.

[Large-scale contact investigation for tuberculosis in Zeist].

Keizer ST, de Vries G, van Deutekom H, van Loenhout JH.

Ned Tijdschr Geneeskd. 2005 Nov 19;149(47):2646; author reply 2646. Dutch. No abstract available.

PMID:
16355580
31.
32.

Characterization of the role of CaMKI-like kinase (CKLiK) in human granulocyte function.

Verploegen S, Ulfman L, van Deutekom HW, van Aalst C, Honing H, Lammers JW, Koenderman L, Coffer PJ.

Blood. 2005 Aug 1;106(3):1076-83. Epub 2005 Apr 19.

PMID:
15840691
33.

Differential regulation of granulopoiesis by the basic helix-loop-helix transcriptional inhibitors Id1 and Id2.

Buitenhuis M, van Deutekom HW, Verhagen LP, Castor A, Jacobsen SE, Lammers JW, Koenderman L, Coffer PJ.

Blood. 2005 Jun 1;105(11):4272-81. Epub 2005 Feb 8.

PMID:
15701714
34.

Mycobacterium tuberculosis, Beijing genotype strains not associated with radiological presentation of pulmonary tuberculosis.

Borgdorff MW, Van Deutekom H, De Haas PE, Kremer K, Van Soolingen D.

Tuberculosis (Edinb). 2004;84(5):337-40.

PMID:
15207809
35.

Clustered tuberculosis cases: do they represent recent transmission and can they be detected earlier?

van Deutekom H, Hoijng SP, de Haas PE, Langendam MW, Horsman A, van Soolingen D, Coutinho RA.

Am J Respir Crit Care Med. 2004 Apr 1;169(7):806-10. Epub 2003 Dec 18.

PMID:
14684559
36.

Enzyme-linked immunosorbent assays using immune complexes for the diagnosis of tuberculosis.

Pereira Arias-Bouda LM, Kuijper S, van Deutekom H, van Gijlswijk R, Pekel I, Jansen HM, Kolk AH.

J Immunol Methods. 2003 Dec;283(1-2):115-24.

PMID:
14659904
37.

Nosocomial Mycobacterium bovis-bacille Calmette-Guérin infections due to contamination of chemotherapeutics: case finding and route of transmission.

Vos MC, de Haas PE, Verbrugh HA, Renders NH, Hartwig NG, de Man P, Kolk AH, van Deutekom H, Yntema JL, Vulto AG, Messemaker M, van Soolingen D.

J Infect Dis. 2003 Nov 1;188(9):1332-5. Epub 2003 Oct 15.

PMID:
14593590
38.
39.

Tuberculin skin test reactions by time of reading among Dutch travellers.

Cobelens F, Van Deutekom H, Draayer-Jansen I, Schepp-Beelen A, Van Gerven P, Mensen M.

Int J Tuberc Lung Dis. 2003 Aug;7(8):758-63.

PMID:
12921152
40.

[Limited tuberculin screening participation amongst travellers to countries with high tuberculosis incidence; reason to consider BCG vaccination for some travellers].

Cobelens FG, Draayer-Jansen EW, Schepp-Beelen JC, van Gerven PJ, van Kessel RJ, van Deutekom H.

Ned Tijdschr Geneeskd. 2003 Mar 22;147(12):561-5. Dutch.

PMID:
12693087
41.

Role of Ca2+/calmodulin regulated signaling pathways in chemoattractant induced neutrophil effector functions. Comparison with the role of phosphotidylinositol-3 kinase.

Verploegen S, van Leeuwen CM, van Deutekom HW, Lammers JW, Koenderman L, Coffer PJ.

Eur J Biochem. 2002 Sep;269(18):4625-34.

42.

Association of tuberculin sensitivity in Dutch adults with history of travel to areas of with a high incidence of tuberculosis.

Cobelens FG, van Deutekom H, Draayer-Jansen IW, Schepp-Beelen AC, van Gerven PJ, van Kessel RP, Mensen ME.

Clin Infect Dis. 2001 Aug 1;33(3):300-4. Epub 2001 Jun 21.

PMID:
11438893
43.

Risk of infection with Mycobacterium tuberculosis in travellers to areas of high tuberculosis endemicity.

Cobelens FG, van Deutekom H, Draayer-Jansen IW, Schepp-Beelen AC, van Gerven PJ, van Kessel RP, Mensen ME.

Lancet. 2000 Aug 5;356(9228):461-5.

PMID:
10981889
44.

How does tuberculosis relate to HIV positive and HIV negative drug users?

Keizer ST, Langendam MM, van Deutekom H, Coutinho RA, van Ameijden EJ.

J Epidemiol Community Health. 2000 Jan;54(1):64-8.

45.

Elevated chemokine concentrations in sera of human immunodeficiency virus (HIV)-seropositive and HIV-seronegative patients with tuberculosis: a possible role for mycobacterial lipoarabinomannan.

Juffermans NP, Verbon A, van Deventer SJ, van Deutekom H, Belisle JT, Ellis ME, Speelman P, van der Poll T.

Infect Immun. 1999 Aug;67(8):4295-7.

46.

Serum concentrations of cytokines in patients with active tuberculosis (TB) and after treatment.

Verbon A, Juffermans N, Van Deventer SJ, Speelman P, Van Deutekom H, Van Der Poll T.

Clin Exp Immunol. 1999 Jan;115(1):110-3.

47.

Serum concentrations of lipopolysaccharide activity-modulating proteins during tuberculosis.

Juffermans NP, Verbon A, van Deventer SJ, Buurman WA, van Deutekom H, Speelman P, van der Poll T.

J Infect Dis. 1998 Dec;178(6):1839-42.

PMID:
9815247
48.

Tumor necrosis factor and interleukin-1 inhibitors as markers of disease activity of tuberculosis.

Juffermans NP, Verbon A, van Deventer SJ, van Deutekom H, Speelman P, van der Poll T.

Am J Respir Crit Care Med. 1998 Apr;157(4 Pt 1):1328-31.

PMID:
9563758
49.

[Tuberculosis in HIV-positive and HIV-negative drug users in Amsterdam].

Keizer ST, Langendam MW, van Deutekom H, Coutinho RA, van Ameijden FJ.

Ned Tijdschr Geneeskd. 1998 Jan 24;142(4):184-9. Dutch.

PMID:
9557024
50.

A molecular epidemiological approach to studying the transmission of tuberculosis in Amsterdam.

van Deutekom H, Gerritsen JJ, van Soolingen D, van Ameijden EJ, van Embden JD, Coutinho RA.

Clin Infect Dis. 1997 Nov;25(5):1071-7.

PMID:
9402360

Supplemental Content

Loading ...
Support Center